Tamara  Fountain net worth and biography

Tamara Fountain Biography and Net Worth

Director of RxSight

Dr. Fountain joined our board of directors in January 2022, at which time she was nominated to serve as a member of the Audit Committee. Dr. Fountain served as the 2021 President of the American Academy of Ophthalmology, the world’s largest association of eye physicians and surgeons and recently returned to Academy service as Secretary for Global Relations in 2025. She was named to the board of directors of the American Board of Ophthalmology in January 2022, where she serves on the Finance and Credentialing Committees. Dr. Fountain was elected to the board of Sight Sciences (NASDAQ:SGHT) in July 2022 where she serves on the Nominating-Governing and Audit Committees. She has been on faculty at Rush University Medical Center in Chicago since May 1998 where she is professor of ophthalmology and section chair emeritus of ophthalmic plastic and reconstructive surgery. She has maintained a private practice, Ophthalmology Partners, Ltd., on Chicago’s North Shore since December 2000. Dr. Fountain was chair for Alumni Fund Giving at Harvard Medical School from January 2016 to June 2019 and served as President of the American Society of Ophthalmic Plastic and Reconstructive Surgery in 2018. She served 15 years on the board of directors of Ophthalmic Mutual Insurance Company, the largest, by market share, professional liability insurer of ophthalmologists in the United States. At the end of her term, Dr. Fountain was elected OMIC’s first woman chair of the Board and chair of the Audit Committee, serving January 2014 to December 2015. She was President of the Illinois Society of Eye Physicians and Surgeons January 2002 to December 2005. Dr. Fountain received her BA in Human Biology from Stanford University in 1984, her MD from Harvard Medical School in 1988 and in 1992, completed her residency in ophthalmology at Johns Hopkins Hospital’s Wilmer Eye Institute.

What is Tamara Fountain's net worth?

The estimated net worth of Tamara Fountain is at least $403,134.18 as of March 12th, 2025. Fountain owns 24,793 shares of RxSight stock worth more than $403,134 as of April 6th. This net worth approximation does not reflect any other investments that Fountain may own. Learn More about Tamara Fountain's net worth.

How do I contact Tamara Fountain?

The corporate mailing address for Fountain and other RxSight executives is , , . RxSight can also be reached via phone at 949-521-7830 and via email at ir@rxsight.com. Learn More on Tamara Fountain's contact information.

Has Tamara Fountain been buying or selling shares of RxSight?

Tamara Fountain has not been actively trading shares of RxSight during the past quarter. Most recently, Tamara Fountain sold 7,000 shares of the business's stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $25.71, for a transaction totalling $179,970.00. Following the completion of the sale, the director now directly owns 24,793 shares of the company's stock, valued at $637,428.03. Learn More on Tamara Fountain's trading history.

Who are RxSight's active insiders?

RxSight's insider roster includes Julie Andrews (Director), Juliet Bakker (Director), Jesse Corley (Director), Tamara Fountain (Director), Ilya Goldshleger (Insider), Ilya Goldshleger (Insider), M Kurtz (CEO), William Link (Director), Shweta Maniar (Director), Shelley Thunen (CFO), Robert Warner (Director), and Eric Weinberg (Insider). Learn More on RxSight's active insiders.

Are insiders buying or selling shares of RxSight?

In the last year, RxSight insiders bought shares 2 times. They purchased a total of 12,554 shares worth more than $549,098.81. In the last year, insiders at the sold shares 28 times. They sold a total of 160,951 shares worth more than $8,269,376.44. The most recent insider tranaction occured on March, 12th when Director Tamara Fountain sold 7,000 shares worth more than $179,970.00. Insiders at RxSight own 9.4% of the company. Learn More about insider trades at RxSight.

Information on this page was last updated on 3/12/2025.

Tamara Fountain Insider Trading History at RxSight

See Full Table

Tamara Fountain Buying and Selling Activity at RxSight

This chart shows Tamara Fountain's buying and selling at RxSight by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100k$0$100kTotal Insider BuyingTotal Insider Selling

RxSight Company Overview

RxSight logo
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Read More

Today's Range

Now: $16.26
Low: $15.01
High: $16.56

50 Day Range

MA: $28.12
Low: $16.21
High: $34.26

2 Week Range

Now: $16.26
Low: $14.37
High: $66.54

Volume

2,105,935 shs

Average Volume

582,609 shs

Market Capitalization

$658.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26